Sean F. Scanlan Treace Medical Concepts, Inc. (TMCI) insider trading activity
Sean F. Scanlan is Chief Innovation Officer of TREACE MEDICAL CONCEPTS, INC.. Currently has a direct ownership of 373,807 shares of TMCI, which is worth approximately $2.7 Million. The most recent transaction as insider was on Mar 08, 2022, when has been sold 6,575 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
374K
2.67%
3M change
49.48%
12M change
Total Value Held
$2.7 Million
Sean F. Scanlan Transaction History
SFS
Sean F. Scanlan
Chief Innovation Officer
Ponte Vedra, FL